(Q43835711)

27 November 2017

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women (English)

1 reference

27 November 2017

1 reference

1 reference

Aliana Guerrieri Gonzaga

0 references

author name string

Bonanni B

1

1 reference

27 November 2017

Johansson H

2

1 reference

27 November 2017

Gandini S

3

1 reference

27 November 2017

Guerrieri-Gonzaga A

4

1 reference

27 November 2017

Torrisi R

5

1 reference

27 November 2017

Sandri MT

6

1 reference

27 November 2017

Cazzaniga M

7

1 reference

27 November 2017

Mora S

8

1 reference

27 November 2017

Robertson C

9

1 reference

27 November 2017

Lien EA

10

1 reference

27 November 2017

Decensi A

11

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Breast Cancer Research and Treatment

27 November 2017

1 reference

27 November 2017

69

1 reference

27 November 2017

1

1 reference

27 November 2017

21-27

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1012241505717

27 November 2017

0 references

cites work

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Role of the insulin-like growth factor family in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and-3 and IGFBP-3 protease activity in boys with normal or precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Serum insulin-like growth factor-I and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

N-desmethyltamoxifen inhibits growth of MCF 7 human mammary carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Comparative studies on the effects of steroidal and nonsteroidal oestrogen antagonists on the proliferation of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Insulin-like growth factors in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

Biologic Activity of Tamoxifen at Low Doses in Healthy Women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

The role of the insulin-like growth factor system in human cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012241505717

7 January 2021

Identifiers

DOI

10.1023/A:1012241505717

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference